Humacyte Inc.

NASDAQ: HUMAW · Real-Time Price · USD
0.49
-0.03 (-5.50%)
At close: Aug 01, 2025, 3:43 PM

Humacyte Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 1.56M 1.26M
Cost of Revenue
7.19M 76.55M 8.26M 49K
Gross Profit
n/a -76.55M -6.69M 1.21M
Operating Income
-114.4M -100.05M -84.58M -81.21M
Interest Income
4.1M 5.47M 2.63M 16K
Pretax Income
n/a -110.78M -11.96M -26.48M
Net Income
-148.7M -110.78M 64.22M 37.54M
Selling & General & Admin
25.8M 20.39M 22.88M 21.13M
Research & Development
88.6M 76.55M 63.26M 61.34M
Other Expenses
n/a -73.44M -1.56M -1.26M
Operating Expenses
114.4M 23.5M 84.58M 81.21M
Interest Expense
9.28M 6.6M 6.2M 4.35M
Selling & Marketing Expenses
n/a -3M n/a n/a
Cost & Expenses
n/a 100.05M 84.58M 81.21M
Income Tax Expense
n/a n/a -76.18M -64.01M
Shares Outstanding (Basic)
118.48M 103.42M 103.05M 39.97M
Shares Outstanding (Diluted)
118.48M 103.42M 103.05M 39.97M
EPS (Basic)
-1.26 -1.07 0.62 0.94
EPS (Diluted)
-1.26 -1.07 0.62 0.94
EBITDA
-132.23M -96.46M 2.49M -72.97M
EBIT
-139.42M -104.18M -84.58M -81.21M
Depreciation & Amortization
7.19M 7.72M 8.26M 8.28M